To cite this paper use one of the standards below:
Myeloperoxidase (MPO) is an oxyreductase enzyme producing reactive species that play a key role in
neutrophil antimicrobial activity. 1 HOCl is the most abundant and important product of MPO, it can chlorinate
biomolecules including proteins, lipids, and nucleic acids at the site of inflammation. MPO is involved in a
growing number of diseases like inflammatory conditions, neurodegenerative diseases, cystic fibrosis, asthma,
atherosclerosis and cancer 2 . Thus, the development of therapeutic strategies for MPO inhibition is increasingly
necessary. This work aims the design, synthesis and pharmacological evaluation of hydrazides derivatives as
MPO inhibitors candidates. In vitro evaluation was performed against MPO-dependent HOCl production
showing that hydrazide derivatives promising good inhibitors of enzymatic activity. 3 The derivative 1a was the
most potent with IC 50 value of 0,15 ± 0,03 μM. In silico studies of docking and molecular dynamics allowed the
proposition of molecular binding modes.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper